Replay Therapeutics, or Replay.bio, is a gene therapy company focused on developing treatments for rare genetic diseases using HSV vectors. It launched Telaria, a subsidiary targeting rare skin diseases. Replay's platform reprograms biology through genome writing.

Replay Therapeutics, or Replay.bio, is a gene therapy company focused on developing treatments for rare genetic diseases using HSV vectors. It launched Telaria, a subsidiary targeting rare skin diseases. Replay's platform reprograms biology through genome writing.